Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Rat (Rattus) FABP3 Anticorps:
anti-Mouse (Murine) FABP3 Anticorps:
anti-Human FABP3 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Monoclonal FABP3 Primary Antibody pour IA, IP - ABIN2191880
Roos, Eymann, Symannek, Duppenthaler, Wodzig, Pelsers, Glatz: Monoclonal antibodies to human heart fatty acid-binding protein. dans Journal of immunological methods 1995
Show all 5 Pubmed References
Human Monoclonal FABP3 Primary Antibody pour IA, IP - ABIN2191881
Guillaume, Zimmermann, Burkhard, Hochstrasser, Sanchez: A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jakob disease. dans Proteomics 2003
Show all 5 Pubmed References
Human Monoclonal FABP3 Primary Antibody pour IA, IP - ABIN2191882
Pelsers, Hanhoff, Van der Voort, Arts, Peters, Ponds, Honig, Rudzinski, Spener, de Kruijk, Twijnstra, Hermens, Menheere, Glatz: Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility. dans Clinical chemistry 2004
Show all 3 Pubmed References
Human Monoclonal FABP3 Primary Antibody pour IA, IP - ABIN2191883
Zhen, Berna, Jin, Pritt, Watson, Ackermann, Hale: Quantification of heart fatty acid binding protein as a biomarker for drug-induced cardiac and musculoskeletal necroses. dans Proteomics. Clinical applications 2010
Show all 3 Pubmed References
Human Monoclonal FABP3 Primary Antibody pour IA, ELISA - ABIN2473917
Kyle: Current concepts on monoclonal gammopathies. dans Australian and New Zealand journal of medicine 1992
Show all 3 Pubmed References
Human Monoclonal FABP3 Primary Antibody pour IA, ELISA - ABIN2473918
Cheon, Kim, Fountoulakis, Lubec: Heart type fatty acid binding protein (H-FABP) is decreased in brains of patients with Down syndrome and Alzheimer's disease. dans Journal of neural transmission. Supplementum 2004
Show all 3 Pubmed References
Human Monoclonal FABP3 Primary Antibody pour WB - ABIN268265
Zhang, Perdomo, Kim, Qu, Ringquist, Trucco, Dong: Proteomic analysis of fructose-induced fatty liver in hamsters. dans Metabolism: clinical and experimental 2008
Human Polyclonal FABP3 Primary Antibody pour IHC (f), IHC (p) - ABIN966114
Phelan, Larsson, Baird, Futreal, Ruttledge, Morgan, Tonin, Hung, Korneluk, Pollak, Narod: The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumors. dans Genomics 1996
Human Polyclonal FABP3 Primary Antibody pour IF, IHC - ABIN6680030
Ni, He, Dai, Yao, Guo, Wei: Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1α-modulated fatty acid metabolism. dans Cell death & disease 2018
Horse (Equine) Polyclonal FABP3 Primary Antibody pour IHC, WB - ABIN2778143
Chen, Zheng, Gao, Ge, Liu: Heart-type fatty acid binding protein is associated with proteinuria in obesity. dans PLoS ONE 2012
Show all 2 Pubmed References
The FABP3 is induced in the mesangial cells and likely a mediator to induce MCP-1 in the diabetic nephropathy.
The results confirmed the altered expression of HFABP, a key fatty acid transport protein, and of enolase and PGK1, the key enzymes in the glycolytic process
Increased placental FABP3 promotes fatty acid transport and contributes to excess lipid accumulation in the fetal liver in model of obesity in pregnancy.
The frameshift and missense mutations in FABP3, FABP5, and FABP7 genes have been identified in schizophrenia and autism spectrum disorder in humans and in mouse behavioral studies.
ABR thresholds of young and aged Fabp3 knockout mice were unchanged compared with those of wild-type mice. Suggests that Fabp3 deficiency alone does not adversely affect hearing function.
Collectively FABP3 regulates n-3 (omega-3) and n-6 (omega-6) polyunsaturated FA transport in trophoblasts and plays a pivotal role in fetal development.
Brown adipocyte-characteristic fatty acid oxidation proteins are induced in beige cells in a different pathway from UCP1.
FABP3 silencing promotes apoptosis and inhibits the proliferation of P19 cells.
FABP3 overexpression has a detrimental effect on mitochondrion function in embryonic cancer P19 cells.
Results indicated that FABP3 knockdown promoted apoptosis and caused mitochondrial dysfunction in P19 cells.
These results suggest that FABP3 stimulates glucose uptake by facilitating AMPK-dependent AS160 phosphorylation in skeletal muscle.
FABP3, is essential for cold tolerance and efficient fatty acid oxidation in mouse brown adipose tissue
results revealed discrete localization of H-FABP and B-FABP in different supporting, not receptor, cell populations of the cochlea of adult mouse
Together, H-FABP is highly expressed in ACh interneurons and glutamatergic terminals, thereby regulating dopamine D2R function in the striatum.
the absence of H-FABP alters rates of FA metabolism and it is also apparent that glucose oxidation is downregulated.
H-FABP isoforms are involved in regulating cardiomyocyte growth and differentiation in mouse neonatal hearts
E-FABP and/or H-FABP are involved in the mediation of dipalmitoyl phosphatidylcholine synthesis in wild type TII cells
H-FABP has roles in heart fatty acid uptake and targeting of fatty acids to specific heart lipid pools and maintenance of phospholipid pool mass
There is a muscle-specific mechanism to enhance binding of the receptor to the response element to ensure action of peroxisome proliferator-activated receptor alpha on the heart-type fatty acid binding protein gene promoter.
H-FABP expression influences brain 20:4n-6 uptake and trafficking as well as steady-state brain lipid levels
Studied use of fatty acid binding protein 3 (FABP3) as a cardiac biomarker for the early identification of myocardial ischemia and infarction in Pakistani patients as compared to Troponini-I (cTnI).
H-FABP can be used as an additional cardiac biomarker in the diagnosis of acute myocardial infarction.
The prognostic value of plasma H-FABP was confirmed in identifying patients with acute pulmonary embolism.
the frequency of h-FABP positivity among acute myocardial infarction patients was higher than that of hs-TnI, which would have missed six of them; however, hs-TnI area under curve was superior to that of h-FABP.
The present study demonstrated that pre-operative FABP3 gene expression in the atrium is reduced in patients with post-operative atrial fibrillation, independent of age and left atrial diameter. These findings suggest a potential link between altered fatty acid transport in the atrium and increased AF onset after cardiac surgery
This study demonstrated that FABP3 CSF levels were increased in the Alzheimer's disease and dementia with Lewy bodies groups compared with the other neurological diseases and Parkinson's disease groups.
Data suggest H-FABP as a potential marker for indicating myocardial ischemia.
Serum levels of FABP3 in polymyositis/dermatomyositis patients were significantly increased and were mainly distributed in slow twitch muscle fibers, displaying a closer association with muscle weakness than did serum levels of CK and myoglobin.
data indicate that FABP3 may in be part involved in ARA uptake in these cells and its expression may be regulated by ARA, insulin, LXR and the state of cellular differentiation.
our research demonstrated that high FABP3 or FABP4 expression had strong prognostic value for overall survival in non-small cell lung cancer
The higher interaction footprint of aptamer N53 incited synergistic conformational changes in both N53 and FABP3 during interaction, leading to a decline in binding affinity in comparison to aptamer N13 which corroborated to the calculated Kd values.
There was no significant correlation between H-FABP, free triiodothyronine (fT3), free thyroxine (fT4), and thyroid stimulating hormone (TSH) levels in hyperthyroid patients
For patients recruited = 6 h after trauma, the CT-positive group indicated significantly higher levels of both H-FABP and S100B than the CT-negative group.
significantly correlated to the major adverse events during hospitalization for acute pulmonary embolism
HFABP expression is significantly elevated in in-stent coronary resteonisis . Overexpression of HFABP induces multiple pathway-related promotion of inflammation, growth and migration in vascular smooth muscle cells.
cardiac damage in patients with CO poisoning could be partially mediated by CO-induced oxidative stress, where H-FABP3 level was directly and strongly associated with MDA and ADMA levels
findings demonstrate the interobserver reliability of a qualitative point of care h-FABP assay
Neonatal phthalate ester exposure induced placental MTs, FATP1 and HFABP mRNA expression
FABP3 expression was significantly lower in the schizophrenia group than in the control group.
This study demonstrated that CSF FABP-3 may be an early marker for later development of dementia.
The expression of H-FABP at both mRNA and protein levels in the tissues of backfat, longissimus dorsi muscle and liver was found to be significantly higher in Tibetan pig than in Large White pig; study provides important data for further investigating the regulatory mechanism of H-FABP for fat deposition in pigs.
SNPs in the FABP3 promoter may contribute to intramuscular fat without influencing carcass fatness traits in pigs
Expression of the FABP3 gene enhances adipogenesis in 3T3-L1 preadipocytes primarily by upregulating lipogenic genes.
Results indicate that fatty acid binding protein H-FABP and CoA ligase 4 ACSL4 genes might serve as markers to improve fat (IMF) content in the breeding system.
hFABP rises faster and correlates better with infarct size and no-reflow than hsTnI in myocardial infarction + reperfusion when measured early after reperfusion.
Linkage disequilibrium analysis among MC4R, LEP and H-FABP revealed that these genes were independent.
The FABP3 polymorphisms can be used as genetic markers in breeding programs for intramuscular fat content as well as carcass back fat thickness.
The H-FABP MspI RFLP genotype affected unsaturated fatty acid content, and the ratio of polyunsaturated fatty acid to saturated fatty acid (P<0.05), whereas the H-FABP HaeIII RFLP genotype had no effect on fatty acid characteristics.
The objective of this study was to investigate the effect of FABP3 and LEPR genetic variations as well as their mRNA expression on the intramuscular fat content trait in a three-generation of Korean native pig and Yorkshire crossed animals.
Results of associated analysis show that the polymorphism of H-FABP gene was associated traits of Intramuscular fat content (IMF) and back fat thickness (BF).
In our study FABP3 genotypes were confirmed to be significantly associated with intramuscular fat in pigs.
Sirt1 regulates the expression of FABP3 gene in adipocytes, and PPAR gamma apparently plays an important role in this process.
Sequence analysis showed that many transcriptional factor binding sites including TATA-box and CCAAT-box were present on the 5'-flanking region of bovine FABP3, and four CpG islands were found on nucleotides from -891 to +118.
FABP3 has a role in milk fat synthesis signaling.
FABP3 gene frequency and SNP genotypes in Holstein-Friesian cows and its relationship with protein and fat content in milk
Thus, the results of our study suggest that the H-FABP and PSMC1 gene polymorphisms could be used as genetic markers in marker-assisted selection for improving Qinchuan beef cattle
polymorphisms can be used to select for milk with lower concentrations of saturated fatty acids and higher concentrations of unsaturated fatty acids
MRF4 and H-FABP genes are associated with growth traits in Qinchuan cattle and related hybrids
fine mapping of this gene to BTA2q45 by fluorescence in situ hybridization and radiation hybrid mapping
The results of this study suggest that suggest that SLC27A6, ACSL1, FABP3, AGPAT6, and LPIN1 coordinately regulate the channeling of fatty acids toward copious milk fat synthesis in bovine mammary.
The intracellular fatty acid-binding proteins (FABPs) belongs to a multigene family. FABPs are divided into at least three distinct types, namely the hepatic-, intestinal- and cardiac-type. They form 14-15 kDa proteins and are thought to participate in the uptake, intracellular metabolism and/or transport of long-chain fatty acids. They may also be responsible in the modulation of cell growth and proliferation. Fatty acid-binding protein 3 gene contains four exons and its function is to arrest growth of mammary epithelial cells. This gene is a candidate tumor suppressor gene for human breast cancer.
Fatty acid binding protein 3 heart
, fatty acid binding protein 3 heart
, fatty acid-binding protein 3
, fatty acid-binding protein, heart
, heart fatty acid binding protein
, heart-type fatty acid-binding protein
, fatty acid binding protein heart 1
, fatty acid binding protein heart 4
, mammary-derived growth inhibitor
, Fatty acid-binding protein 3, muscle
, fatty acid binding protein 11
, muscle fatty acid-binding protein
, heart fatty acid-binding protein
, heart-type fatty acid binding protein
, fatty acid binding protein ( heart ) like